Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt the 0.5mg dose of Wegovy, most side effects are gastrointestinal and tend to be at their most noticeable in the first one to two weeks. Nausea is the most commonly reported, followed by constipation, diarrhoea and burping. For the majority of people, these settle as the body adjusts. Semaglutide is a prescription-only medicine; a clinician assesses your suitability before any treatment begins, and the titration schedule exists partly to keep these effects manageable. You can read the full overview of Wegovy side effects across all doses if you want broader context, but this page focuses specifically on what tends to happen during the 0.5mg phase.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 0.5mg dose sits early in the Wegovy titration schedule, typically reached after four weeks on 0.25mg. By this point the body has had some introduction to semaglutide, but stepping up can still prompt a fresh wave of digestive symptoms. NHS guidance on semaglutide lists the most common effects as nausea, vomiting, diarrhoea, constipation and stomach pain, all of which are more likely when a dose increases.
In practice, nausea is the one people notice most. It tends to peak in the 24 to 48 hours after an injection and gradually quietens. Eating smaller meals, avoiding greasy or very rich food, and not lying flat straight after eating all help. Constipation is the other frequent complaint; keeping fluid intake up and maintaining dietary fibre makes a real difference. Burping, reflux and a feeling of fullness that lingers longer than expected are also reported at this dose.
Fatigue and mild headache appear in some patients during transitions between doses, usually passing within a few days. Injection-site reactions (redness, itching or a small lump at the injection spot) can occur but are generally minor and short-lived. Rotating injection sites across the abdomen, thigh or upper arm helps reduce these.
Most people who experience side effects from Wegovy at this stage find them manageable rather than treatment-ending, but if you want a thorough breakdown of what to expect, our page covering every side effect of Wegovy goes through each one in detail.
There is no fixed answer, because the timeline varies between individuals, but a common pattern is that GI effects are most intense in the first one to two weeks after stepping up to 0.5mg, then ease progressively. Some people find they have virtually no symptoms after the first week; others carry a background queasiness for most of the four-week period at this dose.
A smaller group finds that effects persist more stubbornly. If that happens, the right response is to talk to your prescriber rather than push through alone. Staying at the current dose for longer, adjusting meal timing or composition, or reviewing any other medicines you take are all options a clinician can discuss. The question of how long Wegovy side effects last is covered in more detail on a dedicated page if you want to understand the broader pattern across the full titration schedule.
One thing worth knowing: for some people the 0.5mg phase is actually easier than 0.25mg, because the body has had time to adapt. Side effects do not reliably get worse with each dose increase, response is individual and unpredictable.
If you find you have no side effects on Wegovy at all, that is also a valid and recognised experience. The absence of symptoms is not a sign the medicine is not working.
Most side effects at this dose are self-limiting and manageable at home. A handful are not. Seek urgent medical attention (call 111 or go to A&E depending on severity) in any of the following situations:
Severe or persistent stomach pain, especially if it radiates to your back. This can be a sign of acute pancreatitis, a known but uncommon risk with GLP-1 medicines. The MHRA highlighted acute pancreatitis in a Drug Safety Update for this class of medicine; do not wait to see if it settles. Vomiting alongside this kind of pain makes it more urgent, not less.
Signs of a serious allergic reaction, swelling of the face, lips or throat, difficulty breathing, or a rapid rash spreading across the skin. This is rare but requires emergency care.
Severe dehydration from vomiting or diarrhoea, dry mouth, dizziness on standing, significantly reduced urination. Prolonged GI illness on a GLP-1 medicine can strain kidney function, so dehydration is not something to manage alone indefinitely.
Gallbladder symptoms, sudden severe pain in the upper right abdomen, particularly after eating fatty food, sometimes with fever or jaundice (yellowing of the skin or eyes).
For anything less acute but still concerning, contacting your prescriber promptly is the right step. At nume, aftercare is available seven days a week, our contact page has the details. You can also report suspected side effects directly to the MHRA via the Yellow Card scheme, which helps build real-world safety evidence for medicines like Wegovy.
No, the clinical pathway is the same. A GPhC-registered Independent Prescriber reviews your consultation personally before treatment is issued; that same clinical relationship covers your aftercare. When your prescription is approved and dispatched, the pen arrives via DPD tracked delivery the next working day in a plain, unbranded box, with the Patient Information Leaflet included. The leaflet is a practical first reference for any symptom query.
What matters for safety is that you have a real clinical contact, not just a self-service checkout. Our clinical team is reachable if your symptoms raise questions. The Wegovy overview page covers the full picture of the medicine, including how to verify any online pharmacy on the GPhC register before you hand over personal or medical information, worth doing regardless of which service you use.
Our prescribers discuss suitability and side effects as part of the free consultation. Check your eligibility and start that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.